NASDAQ : XFOR
X4 Pharmaceuticals, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 3.36 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 333.13M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
X4 Pharmaceuticals, Inc. (XFOR) reported revenue of 15.85M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 15.85M | 35.11M | 2.56M | |||
| Cost of Revenue | 2.93M | 5.76M | 797.00K | |||
| Gross Profit | 12.92M | 29.36M | 1.76M | |||
| Selling, General & Admin | 29.35M | 38.52M | 61.52M | 35.51M | 27.02M | 24.70M |
| Research & Development | 64.24M | 70.72M | 81.64M | 72.02M | 61.06M | 50.65M |
| Operating Expenses | 93.59M | 109.24M | 143.16M | 107.52M | 88.08M | 75.35M |
| Operating Income | -80.67M | -79.88M | -141.40M | -107.52M | -88.08M | -75.35M |
| Interest Expense | -8.74M | -8.88M | -8.77M | -5.78M | -3.99M | -3.64M |
| Interest & Investment Income | 6.97M | 4.58M | 5.77M | 4.58M | 219.00K | 10.00K |
| Other Non Operating Income (Expenses) | -490.00K | 12.03M | 2.26M | 7.63M | -2.50M | 60.00K |
| EBT Excluding Unusual Items | -82.93M | -72.16M | -142.14M | -101.09M | -94.35M | -78.92M |
| Merger & Restructuring Charges | -7.24M | -7.00M | ||||
| Impairment of Goodwill | -9.76M | |||||
| Gain (Loss) on Sale of Assets | 105.00M | 509.00K | ||||
| Pretax Income | -90.17M | -79.16M | -37.14M | -101.09M | -93.84M | -88.68M |
| Income Tax Expense | -28.00K | 41.00K | 310.00K | 78.00K | 28.00K | 17.00K |
| Net Income | -90.14M | -79.20M | -37.45M | -101.17M | -93.87M | -88.70M |
| Preferred Dividends & Other Adjustments | 2.55M | 13.94M | ||||
| Net Income to Common | -90.14M | -79.20M | -37.45M | -101.17M | -96.41M | -102.64M |
| Shares Outstanding (Basic) | 101.90M | 42.29M | 6.70M | 5.93M | 2.12M | 858.29K |
| Shares Outstanding (Diluted) | 101.90M | 42.29M | 6.70M | 5.93M | 2.12M | 858.29K |
| EPS (Basic) | -0.88 | -1.87 | -5.59 | -17.07 | -45.53 | -119.59 |
| EPS (Diluted) | -0.89 | -1.87 | -5.59 | -17.07 | -45.53 | -119.59 |
| Free Cash Flow | -83.74M | -85.62M | -131.23M | -96.57M | -77.20M | -71.52M |
| Free Cash Flow Per Share | -0.82 | -2.02 | -19.58 | -16.29 | -36.46 | -83.33 |
| Gross Margin | 81.51% | 83.60% | 68.83% | |||
| Operating Margin | -509.06% | -227.50% | -5,529.96% | |||
| Profit Margin | -568.80% | -225.56% | -1,464.61% | |||
| Free Cash Flow Margin | -528.40% | -243.84% | -5,132.07% | |||
| EBITDA | -79.00M | -78.61M | -140.60M | -107.10M | -87.56M | -74.85M |
| EBITDA Margin | -223.87% | |||||
| D&A For EBITDA | 1.67M | 1.28M | 796.00K | 419.00K | 513.00K | 499.00K |
| EBIT | -80.67M | -79.88M | -141.40M | -107.52M | -88.08M | -75.35M |
| EBIT Margin | -227.50% | |||||
| Revenue as Reported | 15.85M | 35.11M | 2.56M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 195.09M | 217.05M | 55.70M | 99.22M | 121.72M | 81.79M |
| Short-Term Investments | 12.87M | 35.95M | 46.36M | 15.00M | ||
| Cash & Short-Term Investments | 207.97M | 253.00M | 102.06M | 114.22M | 121.72M | 81.79M |
| Accounts Receivable | 2.05M | 573.00K | 1.07M | |||
| Other Receivables | 640.00K | 562.00K | 1.15M | 747.00K | ||
| Receivables | 2.05M | 573.00K | 1.71M | 562.00K | 1.15M | 747.00K |
| Inventory | 5.50M | 4.48M | 2.82M | |||
| Prepaid Expenses | 2.76M | 2.52M | 5.59M | 7.05M | 5.52M | 5.34M |
| Restricted Cash | 579.00K | 803.00K | 250.00K | 285.00K | ||
| Other Current Assets | 200.00K | |||||
| Total Current Assets | 218.85M | 261.58M | 112.17M | 122.08M | 128.68M | 87.88M |
| Property, Plant & Equipment | 765.00K | 1.59M | 4.84M | 6.39M | 8.33M | 10.22M |
| Goodwill | 17.35M | 17.35M | 17.35M | 17.35M | 17.35M | 17.35M |
| Other Intangible Assets | 13.10M | 9.25M | 10.00M | |||
| Long-Term Deferred Charges | 500.00K | |||||
| Other Long-Term Assets | 2.99M | 192.00K | 2.08M | 1.44M | 1.23M | 1.72M |
| Total Assets | 253.06M | 290.46M | 146.45M | 147.26M | 155.59M | 117.18M |
| Accounts Payable | 3.93M | 5.70M | 8.62M | 8.95M | 7.78M | 4.28M |
| Accrued Expenses | 14.12M | 18.60M | 23.00M | 12.82M | 11.44M | 7.84M |
| Current Portion of Long-Term Debt | 1.31M | 795.00K | ||||
| Current Portion of Leases | 465.00K | 994.00K | 1.25M | 1.10M | 1.20M | 1.07M |
| Current Unearned Revenue | 842.00K | 464.00K | ||||
| Other Current Liabilities | 591.00K | 25.00K | ||||
| Total Current Liabilities | 19.37M | 25.76M | 32.88M | 22.86M | 22.32M | 14.02M |
| Long-Term Debt | 76.76M | 76.29M | 75.42M | 54.57M | 32.30M | 33.14M |
| Long-Term Leases | 1.41M | 2.61M | 3.60M | 4.78M | ||
| Long-Term Unearned Revenue | 592.00K | 621.00K | ||||
| Other Long-Term Liabilities | 892.00K | 1.50M | 14.59M | 16.11M | 23.30M | 826.00K |
| Total Liabilities | 97.61M | 104.17M | 124.30M | 96.16M | 81.53M | 52.76M |
| Common Stock | 96.00K | 91.00K | 6.00K | 167.00K | 122.00K | 28.00K |
| Additional Paid-In Capital | 786.43M | 780.86M | 537.62M | 528.96M | 450.79M | 347.37M |
| Retained Earnings | -630.95M | -594.55M | -515.36M | -477.90M | -376.74M | -282.87M |
| Comprehensive Income & Other | -123.00K | -109.00K | -122.00K | -119.00K | -119.00K | -119.00K |
| Total Common Equity | 155.45M | 186.29M | 22.15M | 51.10M | 74.05M | 64.41M |
| Shareholders' Equity | 155.45M | 186.29M | 22.15M | 51.10M | 74.05M | 64.41M |
| Total Liabilities & Equity | 253.06M | 290.46M | 146.45M | 147.26M | 155.59M | 117.18M |
| Total Debt | 77.22M | 77.28M | 78.09M | 58.28M | 38.42M | 39.78M |
| Net Cash (Debt) | 130.75M | 175.71M | 23.97M | 55.94M | 83.30M | 42.00M |
| Net Cash Per Share | 1.28 | 4.15 | 3.58 | 9.44 | 39.34 | 48.94 |
| Filing Date Shares Outstanding | 99.15M | 90.92M | 5.79M | 5.60M | 4.07M | 1.03M |
| Total Common Shares Outstanding | 96.11M | 90.91M | 5.70M | 5.58M | 4.06M | 937.59K |
| Working Capital | 199.49M | 235.82M | 79.30M | 99.21M | 106.35M | 73.86M |
| Book Value Per Share | 1.62 | 2.05 | 3.89 | 9.16 | 18.26 | 68.70 |
| Tangible Book Value | 125.00M | 159.69M | -5.20M | 33.75M | 56.70M | 47.06M |
| Tangible Book Value Per Share | 1.30 | 1.76 | -0.91 | 6.05 | 13.98 | 50.19 |
| Machinery | 1.22M | 1.19M | 2.43M | 2.11M | 2.08M | 1.98M |
| Leasehold Improvements | 228.00K | 228.00K | 228.00K | 228.00K | 228.00K | 228.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -90.14M | -79.20M | -37.45M | -101.17M | -93.87M | -88.70M |
| Depreciation & Amortization | 1.67M | 1.28M | 796.00K | 419.00K | 513.00K | 499.00K |
| Other Amortization | 897.00K | 865.00K | 856.00K | 929.00K | 918.00K | 756.00K |
| Loss (Gain) From Sale of Assets | -105.00M | |||||
| Asset Writedown & Restructuring Costs | 9.76M | |||||
| Stock-Based Compensation | 8.53M | 4.30M | 8.20M | 8.69M | 5.20M | 6.18M |
| Other Operating Activities | 1.56M | -10.28M | -982.00K | -5.72M | 4.40M | 2.10M |
| Change in Accounts Receivable | -903.00K | 497.00K | -1.07M | |||
| Change in Inventory | -2.33M | -1.66M | -2.82M | |||
| Change in Accounts Payable | -3.78M | -2.98M | -286.00K | 1.23M | 3.42M | 1.17M |
| Change in Unearned Revenue | -147.00K | 1.08M | ||||
| Change in Other Net Operating Assets | 911.00K | 483.00K | 6.85M | -890.00K | 2.31M | -2.66M |
| Operating Cash Flow | -83.74M | -85.62M | -130.90M | -96.51M | -77.10M | -70.91M |
| Capital Expenditures | -326.00K | -60.00K | -103.00K | -615.00K | ||
| Sale of Property, Plant & Equipment | 105.00M | |||||
| Sale (Purchase) of Intangibles | -5.00M | -3.00M | -7.00M | |||
| Investment in Securities | 11.43M | 11.15M | -30.68M | -14.82M | ||
| Investing Cash Flow | 6.43M | 8.15M | 66.99M | -14.88M | -103.00K | -615.00K |
| Long-Term Debt Issued | 20.00M | 22.50M | ||||
| Long-Term Debt Repaid | -2.06M | -795.00K | ||||
| Net Debt Issued (Repaid) | 20.00M | 20.44M | -795.00K | |||
| Issuance of Common Stock | 233.07M | 238.63M | 294.00K | 68.71M | 122.84M | 76.25M |
| Repurchase of Common Stock | -12.00K | -2.00M | ||||
| Other Financing Activities | -631.00K | -4.80M | ||||
| Financing Cash Flow | 233.07M | 238.63M | 20.29M | 88.52M | 117.23M | 74.25M |
| Foreign Exchange Rate Adjustments | -23.00K | 213.00K | -156.00K | 99.00K | -105.00K | -319.00K |
| Net Cash Flow | 155.75M | 161.38M | -43.77M | -22.78M | 39.92M | 2.41M |
| Free Cash Flow | -83.74M | -85.62M | -131.23M | -96.57M | -77.20M | -71.52M |
| Free Cash Flow Margin | -528.40% | -243.84% | -5,132.07% | |||
| Free Cash Flow Per Share | -0.82 | -2.02 | -19.58 | -16.29 | -36.46 | -83.33 |
| Levered Free Cash Flow | -53.31M | -57.36M | -83.72M | -59.79M | -44.23M | -43.05M |
| Unlevered Free Cash Flow | -48.74M | -52.68M | -79.09M | -57.10M | -42.65M | -41.53M |
| Cash Interest Paid | 8.05M | 8.05M | 7.77M | 4.60M | 3.01M | 2.91M |
| Cash Income Tax Paid | 338.00K | 338.00K | ||||
| Change in Working Capital | -6.25M | -2.58M | 2.67M | 344.00K | 5.74M | -1.50M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 332.14M | 349.75M | 125.11M | 140.27M | 120.68M | 64.41M |
| Enterprise Value | 201.40M | 304.91M | 68.34M | 56.88M | 79.15M | 27.86M |
| Last Close Price | 3.35 | 4.00 | 22.01 | 25.16 | 29.79 | 68.70 |
| PS Ratio | 20.96 | 9.96 | 48.93 | |||
| PB Ratio | 2.07 | 1.88 | 5.65 | 2.75 | 1.63 | 1.00 |
| P/TBV Ratio | 2.66 | 2.19 | 4.16 | 2.13 | 1.37 | |
| EV/Sales Ratio | 12.71 | 8.68 | 26.73 | |||
| Debt / Equity Ratio | 0.50 | 0.41 | 3.52 | 1.14 | 0.52 | 0.62 |
| Net Debt / Equity Ratio | -0.84 | -0.94 | -1.08 | -1.09 | -1.12 | -0.65 |
| Net Debt / EBITDA Ratio | 1.66 | 2.23 | 0.17 | 0.52 | 0.95 | 0.56 |
| Net Debt / FCF Ratio | 1.56 | 2.05 | 0.18 | 0.58 | 1.08 | 0.59 |
| Asset Turnover | 0.09 | 0.16 | 0.02 | |||
| Inventory Turnover | 0.68 | 1.58 | ||||
| Quick Ratio | 10.85 | 9.85 | 3.16 | 5.02 | 5.50 | 5.89 |
| Current Ratio | 11.30 | 10.16 | 3.41 | 5.34 | 5.76 | 6.27 |
| Return on Equity (ROE) | -113.08% | -75.99% | -102.26% | -161.67% | -135.58% | -129.28% |
| Return on Assets (ROA) | -28.15% | -22.86% | -60.18% | -44.38% | -40.36% | -39.24% |
| Return on Capital Employed (ROCE) | -34.50% | -30.20% | -124.50% | -86.40% | -66.10% | -73.00% |
| Earnings Yield | -26.47% | -22.64% | -29.93% | -72.12% | -77.78% | -137.70% |
| FCF Yield | -25.21% | -24.48% | -104.89% | -68.84% | -63.97% | -111.04% |
| Buyback Yield / Dilution | -1,374.07% | -531.04% | -13.08% | -179.91% | -146.71% | -28.25% |